Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Mateusz Janusz Mezynski"'
Autor:
Sinead Toomey, Aoife Carr, Mateusz Janusz Mezynski, Yasir Elamin, Shereen Rafee, Mattia Cremona, Clare Morgan, Stephen Madden, Khairun I. Abdul-Jalil, Kathy Gately, Angela Farrelly, Elaine W. Kay, Susan Kennedy, Kenneth O’Byrne, Liam Grogan, Oscar Breathnach, Patrick G. Morris, Alexander J. Eustace, Joanna Fay, Robert Cummins, Anthony O’Grady, Roshni Kalachand, Norma O’Donovan, Fergal Kelleher, Aine O’Reilly, Mark Doherty, John Crown, Bryan T. Hennessy
Publikováno v:
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-14 (2020)
Abstract Background An increasing number of anti-cancer therapeutic agents target specific mutant proteins that are expressed by many different tumor types. Successful use of these therapies is dependent on the presence or absence of somatic mutation
Externí odkaz:
https://doaj.org/article/b0a3ce4f632e46aeb43bc18b4d3e61a7
Autor:
Oscar S. Breathnach, Kathy Gately, Robert Cummins, Mattia Cremona, Elaine W. Kay, A. O'Reilly, Khairun I. Abdul-Jalil, Alex J Eustace, Mateusz Janusz Mezynski, Kenneth J. O'Byrne, Patrick G. Morris, Norma O'Donovan, Susan Kennedy, Joanna Fay, Stephen F. Madden, Fergal C. Kelleher, Liam Grogan, John Crown, Anthony O'Grady, Clare Morgan, Mark A. Doherty, Roshni Kalachand, Aoife Carr, Bryan T. Hennessy, Shereen Rafee, Sinead Toomey, Angela M. Farrelly, Yasir Y. Elamin
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-14 (2020)
Journal of Translational Medicine, Vol 18, Iss 1, Pp 1-14 (2020)
Background An increasing number of anti-cancer therapeutic agents target specific mutant proteins that are expressed by many different tumor types. Successful use of these therapies is dependent on the presence or absence of somatic mutations within
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f46390be5d8021569928035d2b37e6d2
https://doi.org/10.1186/s12967-020-02273-4
https://doi.org/10.1186/s12967-020-02273-4